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1. Introduction  
The biological activity of most proteins is determined by their 3D structure. For instance, a 
substantial number of molecular diseases are caused by protein structural alterations, which 
are genetically encoded. Drugs operate by binding to proteins, inducing alteration of their 
functional structure and thereby affecting their biological activity. Hence the design and 
improvement of drugs is greatly facilitated by knowledge of the 3D structures of their 
macromolecular targets. In the light of these considerations, it is clear that elucidation of the 
3D structure of proteins is of prime importance for understanding the underlying 
mechanisms of molecular diseases. It was initially believed that any protein that could be 
made soluble and could be purified would be relatively easy to crystallize. However, the 
results have indicated that solubility and purity of proteins, although being important 
factors, do not secure a yield of useful crystals. The crystallization behavior of proteins turns 
out to be very complex.  
In an effort to identify the naturally occurring protein folds, large structural genomics 
consortia were set up. The somewhat disappointing outcome of these efforts is that only 
about 3% of all proteins that were targeted by these consortia yielded a crystal structure 
(http://targetdb.pdb.org/statistics/TargetStatistics.html), despite massive investments in 
high-throughput, automated protein production, purification and crystallization. It is clear 
that in order to improve the current situation, better strategies for protein crystallization are 
required, combined with techniques that allow the use of smaller nano-crystalline material. 
2. Crystallization of bio-macromolecules 
Biocrystallization involves the three classical steps of nucleation, growth, and cessation of 
growth, even though the protein crystals contain on average 50% of disordered solvent 
(Figure 1) (Matthews et al., 1968). However, crystal growth of biological molecules differs 
substantially from small molecule crystalogenesis. The reason is the much larger number of 
parameters involved in biocrystallization, as well as the specific physico-chemical properties 
of the biological compounds. The main difference from small molecule crystal growth is the 
conformational flexibility and chemical versatility of macromolecules and their greater 
sensitivity to external factors. An overview of different parameters affecting the 
crystallization of biomacromolecules is presented in table 1 (Bergfors T, 2009).  
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Fig. 1. Crystal packing in lysozyme crystals (pdb:1Lyz) shows large cavities. These cavities 
are filled with disordered solvent (not shown). 
 
Intrinsic physico-chemical properties 
 Supersaturation 
 Temperature, pH 
 Ionic strength and purity of 
chemicals 
 Pressure, electric and magnetic fields 
 Vibration and sound 
Biochemical and biophysical parameters 
 Sensitivity of conformation to physical 
parameters 
 Binding of ligands 
 Specific additives 
 Aging of samples 
Biological parameters 
 Rarity of biological macromolecules 
 Bacterial contaminants 
 Biological sources of organisms and 
cells 
Purity of macromolecules 
 Macromolecular contaminants 
 Sequence (micro) heterogeneity 
 Conformational (micro) heterogeneity 
 Batch effects 
Table 1. Overview of parameters affecting bio-macromolecular crystallization. 
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Another important prerequisite for successful crystallization is the quality of the 
macromolecular samples. Bio-macromolecules are extracted from living cells or synthesized 
in vitro and they are frequently difficult to prepare at a high degree of purity and 
homogeneity. Besides traces of impurities, the different treatments proteins are subjected to 
may decrease their stability and activity through different kinds of alterations. As a general 
rule, purity and homogeneity are regarded as conditions of prime importance. Accordingly, 
purification, stabilization, storage and handling of macromolecules are other essential steps 
prior to crystallization.  
3. Purity of bio-macromolecular samples  
The concept of purity has a special meaning when biological crystallogenesis is concerned. 
Molecular samples need to be not only chemically pure, but they must also be 
conformationally uniform (Giege et al., 1986). This concept is based on the fact that the best 
crystals are grown from solutions containing well-defined entities with identical physico-
chemical properties. For X-ray crystallographic studies, the aim is to grow ‘single crystals’ 
diffracting to high resolution with a low mosaicity and prolonged stability in the X-ray 
beam. It is therefore understandable that contaminants may compete for sites on the 
growing crystals and generate lattice errors leading to internal disorder, dislocations, poor 
diffraction or early cessation of growth (Vekilov et al., 1996). Because of the high molecular 
weight of molecules in a single crystal (up to millions of daltons), and hence low molarity of 
their solutions even relatively small amounts of contaminant may induce formation of non-
specific aggregates, alter macromolecular solubility, or interfere with nucleation and crystal 
growth (Skouri et al., 1996; McPherson et al., 1996). Successful crystallization of rare proteins 
and nucleic acids support the importance of purity and homogeneity (Wierenga et al., 1987; 
Thegesen et al., 1996; Aoyama et al., 1996; Douna et al.,: 1993). Usually most of the 
contaminants are eliminated during the different purification steps, however traces of 
polysaccharides, lipids or proteases may still be present and hinder crystallization. Small 
molecules, like peptides, oligonucleotides, amino acids, as well as uncontrolled ions should 
also be considered as contaminants. Buffering molecules remaining from a purification step 
can be responsible for irreproducible crystallization. For instance, phosphate ions are 
relatively difficult to remove and may crystallize in the presence of divalent cations (Ca2+, 
Mg2+). Counterions play a critical role in the packing of biomolecules. Often macromolecules 
do not crystallize or yield different habits in the presence of various buffers adjusted at the 
same pH.  
Bio-molecular samples containing traces of contaminants can further be subjected to 
purification through recrystallization, column chromatography, ultra-centrifugation, 
fractionated precipitation, affinity purification and other techniques. Microheterogeneity 
in pure macromolecules can only be revealed by very sensitive methods. The most 
common causes for heterogeneity are uncontrolled fragmentation and post-synthetic 
modification.  
Proteolysis normally takes place in many physiological processes and represents a major 
difficulty that needs to be overcome during protein extraction from the living cells that 
produce the desired protein (Achstetter et al., 1985; Barrett et al., 1986; Dalling et al., 1986; 
Bond et al., 1987; Arfin et al., 1988; Wandersman et al., 1989). The reason is that proteases are 
localized in various cellular compartments or excreted in the extracellular medium. Upon 
cell disruption, cellular compartments are mixed with extracellular proteases and control 
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over proteolysis is lost. Decrease of protein size and stability, modification of their charge or 
hydrophobicity, partial or total loss of activity are usually signs of proteolysis. Traces of 
protease may not be detectable even when overloading electrophoresis gels, but they can 
cause damage during concentration or storage of samples. 
Co- or post-translational enzymatic modifications generate microheterogeneity in proteins 
when different groups, for instance oligosaccharide chains, occupy specific modification 
sites on the protein, or when correct modifications are unevenly distributed. Only certain 
modifications are reversible, for instance phosphorylation, but others like glycosylation or 
methylation are not. Microheterogeneity can also appear during storage, for instance by 
deamidation of asparagines or glutamine residues is a well-documented phenomenon. 
Pure, chemically uniform macromolecules can be fully functional in a biochemical activity 
assay even though they are microheterogeneous. Conformational heterogeneity may have 
several origins: binding of ligands, intrinsic flexibility of molecular backbones, oxidation of 
cysteine residues or partial denaturation. In the first case, macromolecules should be 
prepared in both forms, the one deprived of and the other saturated with ligands. In the 
second case, controlled fragmentation may be helpful. In the last one, oxidation of a single 
cysteine residue leads to complex mixtures of molecule species for which the chances of 
growing good crystals are low (Van der Laan et al., 1989). 
Although macromolecules may crystallize readily in an impure state (Holley et al., 1961), 
this is an exception and it is always preferable to achieve a high level of purity before 
starting crystallization experiments. In order to gain more information about the quality of 
the protein samples, different techniques can be used. For instance, spectrophotometry and 
fluorometry give information about the quality of samples if macromolecules or their 
contaminants have special absorbance or emission properties. SDS-PAGE indicates the size 
of protein contaminants, but not that of non-protein contaminants. Isoelectric focusing gives 
an estimate of the pI of protein components in a mixture and electrophoretic titration shows 
the mobility of individual proteins as a function of pH. The latter method can also suggest 
the type of chromatography suitable for further purification. Capillary electrophoresis is 
well adapted for purity analysis (Karger et al., 1996). Amino acid composition and 
sequencing of N- and C- termini verify in part the integrity of primary structure.  
Electrospray ionization and matrix-assisted laser desorption/ionisation mass spectrometry 
are also powerful tools in the analysis of recombinant protein chemistry. Nuclear magnetic 
resonance can detect small size contaminants and gives structural information on 
biomolecules (Wuthrich , 1995). 
It is widely believed that the success of crystal trials is largely dependent on various, not 
very well identified, properties of the protein. For example, a positive correlation has been 
established between the degree of protein monodispersity in solution and the ability of the 
protein to crystallize. On the other hand, it’s thought to be a negative correlation between 
the degree of disorder in the protein and its ability to crystallize (Mikol et al., 1989). 
A number of biophysical techniques and methods are employed to evaluate the quality and 
stability of protein solutions. Dynamic light scattering is a useful tool for non-invasive in situ 
monitoring of crystallization trials because it detects the formation of aggregates or nuclei 
before they become visible under a light microscope (Berne et al., 1976). Fluorescence and 
light scattering are helpful to rapidly identify stabilizing conditions compromising simple 
agents (salts, co-factors etc.). Emission fluorescence is used to measure changes if the protein 
unfolds or undergoes other conformational changes (Konev et al. 1967). 
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4. Solubility, supersaturation and phase transition  
Biological macromolecules follow the same thermodynamic rules as inorganic or organic 
small molecules concerning supersaturation, nucleation and crystal growth. However, 
protein macromolecules are organized in tertiary and quaternary structures. The intra-
molecular interactions responsible for their tertiary structure, the intermolecular interactions 
involved in the crystal contacts, and the interactions necessary to solubilise them in a solvent 
are similar.  
To crystallize a biological macromolecule, its solution must have reached supersaturation, 
which is the driving force for crystal growth. The under- and supersaturated states are 
defined by the solubility of the macromolecules. When the concentrations of the 
crystallization agent and the macromolecules correspond to the solubility condition, the 
saturated macromolecule solution is in equilibrium with the crystallized macromolecules. 
Below the solubility curve (fig. 2) the solution is under saturated and the system is 
thermodynamically stable. In this case, phase transition (crystallization) will not occur. 
Above the solubility curve, the concentration of the biological macromolecules is higher 
than the concentration at equilibrium. A supersaturated macromolecular solution contains 
an excess of macromolecules that will appear as a solid phase until the macromolecular 
concentration reaches the solubility value in the solution. The higher the supersaturation, 
the faster this solid phase appears. However, at very high supersaturation precipitation, not 
crystallization occurs, but insoluble macromolecules rapidly separate from the solution in an 
amorphous state.  
 
 
Fig. 2. Solubility curve of a protein, where the phase state of the protein is plotted against 
the concentration of both protein and precipitant. At the point (1), the protein may 
precipitate so fast that an amorphous precipitate or at best shower of microcrystals is 
formed. At (2) the conditions are just right for the protein to form a stable crystal nucleus, 
which will start to grow – passing (3) – into a stable protein at equilibrium with the mother 
liquor (4). At (5), the concentration of protein and precipitant are too low for crystal 
nucleation or growth, and the solution will remain clear. Note that the true solubility curve 
of any protein is highly multidimensional, with every parameter affecting protein solubility 
(cf. Table 1) representing a different independent axis. 
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Fig. 3. Glucose Isomerase crystallization condition yielding phase separation (far left) 
amorphous precipitation (near left) micro-crystals (near right) and macro-crystals (far right) 
bar on the top left represents 200 micrometer. 
5. Crystallization strategies  
5.1 Crystallization screens  
Finding crystallization conditions for a new protein target is largely based on a trial and 
error method. The first step is to set up screening trials, exposing the protein to a variety of 
agents in order to find useful “leads“, which can be crystals, crystalline precipitates and 
phase separation that point to conditions that are conductive to crystallization. 
The most popular screens to perform the initial screening step are called sparse-matrix 
screens. These screens rely on a compilation of conditions that had previously led to 
successful crystallization. Systematic screens sample the crystallization parameter space in a 
balanced, rational way using information on the protein properties. Systematic screens are 
usually used as second remedy or in order to optimize the crystallization conditions.  
5.2 Choosing the crystallization method 
There are different methods to crystallize biological macromolecules. However, all of them 
aim at bringing the solution of macromolecules to a supersaturation state (McPherson, 1985; 
Giege, 1987). It’s important to keep in mind that not only the various chemical and physical 
parameters influence protein nucleation and crystallization, but also the method of 
crystallization. Therefore, it’s wise to try different methods when searching for optimal 
crystallization conditions. As solubility is dependent on temperature (it could increase or 
decrease depending on the protein), it’s highly recommended to perform crystallization 
trials at constant temperature unless temperature variation is part of the experiment. 
Solubility of most chemicals is given in Merck Index. The chemical nature of the buffer is an 
important parameter for protein crystal growth. It must be kept in mind that the pH of 
buffers is often temperature dependent, this is particularly significant for Tris buffers. 
Buffers, which must be used within one unit from their pK value, are well described in 
textbooks (Perin et al., 1974). 
Protein samples often contain large amount of salts of unknown composition when first 
obtained. Thus it’s wise to dialyse a new batch of a macromolecule against a large volume of 
well-characterised buffer of given pH, to remove unwanted salts and to adjust the pH. 
Starting from known conditions helps to increase the reproducibility. 
Whatever the crystallization method used, it requires high concentration of biological 
macromolecules as compared to normal biochemistry conditions. Before starting a 
crystallization experiment, a concentration step is generally needed. It’s also important to 
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keep pH and ionic strength at desired value, since pH may vary when the concentration of 
macromolecules increases. Also, low ionic strength could lead to early precipitation. Many 
commercial devices are available based on Different concentration principles such as 
concentration under pressure, using centrifugation, or lyophilisation. The choice of method 
for concentration depends on the quantity and the stability of the macromolecules. 
Before a crystallization experiment, solid particles such as dust, denatured proteins, and 
solids coming from purification columns or lyophilization should be removed. This could be 
achieved by centrifugation or filtration, depending on the available quantity. 
The most common method to measure macromolecular concentration is to sample an 
aliquot, dilute it with buffer, and measure absorbance at 280 nm for proteins within the 
linear range of a spectrophotometer. Proper subtraction with the reference cell should be 
made especially when working with additives absorbing in the 260-300 nm wavelength 
range. When working with enzymes, an alternative method to measure the concentration of 
protein is to perform activity test, otherwise colorimetric methods can be performed. 
5.2.1 Vapour diffusion 
The most widely used method of crystallization is vapour diffusion. The protein solution 
is a hanging, sitting or sandwich drop that equilibrates against a reservoir containing 
crystallizing agents at either higher or lower concentration than in the drop. Equilibration 
proceeds by diffusion of the volatile species (water or organic solvent) until vapour 
pressure in the droplet equals the one of the reservoir. If equilibration occurs by water 
exchange from the drop to the reservoir, it leads to a droplet volume decrease. 
Consequently, the concentration of all constituents in the drop will increase. For species 
with a vapour pressure higher than water, the exchange occurs from the reservoir to the 
drop. In such a ‘reverse’ system, the drop volume will increase and the concentration of 
the drop constituents will decrease. The same principle applies for hanging drops, sitting 
drops and sandwich drops. Most people use a ratio of 1:1 between the concentration of 
the crystallizing agent in the reservoir and in the droplet. This is achieved by mixing a 
droplet of protein at twice the desired final concentration. When no crystal or precipitate 
is observed, either supersaturation is not reached or one has reached the metastable 
region. In the latter case changing the temperature by a few degrees is generally sufficient 
to initiate nucleation. Although unique in this respect, vapour diffusion permit easy 
variation of physical parameters during crystallization, and many successes were 
obtained by modifying supersaturation by temperature or pH changes. With ammonium 
sulphate as the crystallizing agent, it has been shown that the pH in the droplets is 
imposed by that of the reservoir. Consequently, varying the pH of the reservoir permits 
gentle adjustments of that in the droplets. From another point of view sitting drops are 
well suited for attempting epitaxial growth of macromolecule crystals on appropriate 
mineral matrices. In other words vapour diffusion provides a way to sample the 
crystallization space with the conditions continuously varying, as the equilibration 
proceeds. The kinetics of water evaporation determines the kinetics of supersaturating 
and accordingly affects nucleation rates. Evaporation rates from hanging drops have been 
determined experimentally in the presence of ammonium sulphate, PEG, MPD and NaCl 
as crystallizing agents. The main parameters that determine the rate of water equilibration 
are temperature, initial drop volume, water pressure of the reservoir, and the chemical 
nature of the crystallization agent. Theoretical modelling has shown in addition the 
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pivotal role of the drop to reservoir distance. It was shown that the effect of this 
parameter is negligible in classical set-ups and becomes only noticeable when drop to 
reservoir distance is more than 2 cm. From practical point of view, the time for water 
evaporation to reach 90% completion can vary from about 25 hours to more than 25 days. 
The fastest equilibration occurs in the presence of ammonium sulphate and the slowest in 
the presence of PEG. Equilibration rates are significantly slowed down by increasingly 
appropriately the distance between the drop and the reservoir. An alternative solution to 
decrease equilibration rates is to apply a layer of oil over the reservoir. 
 
 
Fig. 4. Schematic drawing of sitting drop (left), hanging drop (middle), and batch 
crystallization (right). Well solution is blue, protein mixed with well solution is brown and 
oil is green. 
5.2.2 Batch crystallization methods 
Another routinely used method for crystallization is the batch method. The biological 
macromolecule to be crystallized is mixed with the crystallizing agent at a concentration 
such that supersaturation is instantaneously reached. Crystallization trials are dispensed 
and incubated under low-density paraffin oil. The crystallization drops remain under oil, 
where they are protected from evaporation, contamination and shock. Since supersaturation 
is reached at the start of the experiment, nucleation tends to be higher, if compared to the 
vapour diffusion method. However, in some cases fairly large crystals can be obtained when 
working close to the metastable region. Although the microbatch method has not been 
compared in a statistically significant scale against hanging drop-vapour diffusion method, 
a comparison on a small scale has been performed (Baldok et al., 1999). The study 
demonstrated that the methods are not entirely identical, but are equally effective. The 
results suggest that vapour diffusion method and the microbatch technique will probably 
produce similar numbers of crystals, but may not produce crystals for the same conditions. 
Microbatch and vapour diffusion methods are both suitable for high throughput 
crystallization experiments where all the steps of dispensing, mixing and sealing are 
automated and performed by a robot.  Other crystallization methods worth mentioning, 
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although with more limited success and use are crystallization in gel, dialysis, microfluidics, 
free interface diffusion. Microfluidic chips are also being used for high throughput 
crystallization screening. 
5.2.3 Crystallization in gels 
Special attention has been paid to crystallization in gels (Robert at al., 1987). The protein 
crystallization process consists of two main steps – the transport of growth units towards 
the surface of the crystals and second, the incorporation of the growth units into a crystal 
surface position of high bond strength. The whole growth process is dominated by the 
slower of these two steps and is either transport controlled or surface controlled. The ratio 
between transport to surface kinetics, which can be tuned by either enhancing or reducing 
transport processes in solution, was shown to control the amplitude of growth rate 
fluctuations. These are the reasons why gels if properly designed are expected to enhance 
the quality of crystals. It’s worth mentioning that crystals growing in gel do not sediment 
as they do in free solution. They develop at the nucleation site, sustained by the gel 
network. For small molecule crystals grown in silica gel, the gel often forms cusp-like 
cavities around the crystal and a thin liquid film that reduces contamination risk, 
separates the crystal from the gel. Such cavities have not been seen in macromolecular 
crystals. Recent studies have shown that silica gel can be incorporated in the crystal 
network almost without disturbing the crystal lattice. Such crystals that still diffract to a 
high resolution, are mechanically reinforced and are more resistant to dehydration, 
because the silica gel framework embedded in the crystal slows down water loss due to its 
hygroscopic properties. Although seeding can be used, it appears that most of the gel-
grown crystals are obtained by spontaneous nucleation inside a macroscopically 
homogeneous gel. When the gel adheres to the walls of the container, no nucleation 
occurs on the cell walls, neither on dust. So, heterogeneous nucleation is strongly reduced, 
if not suppressed. Another type of nucleation, namely secondary nucleation, is due to 
attrition of a previous crystal by the solution flux. When nucleation occurs inside the gel, 
one observes that all the crystals appear at the same time and have about the same size. 
They are homogenously distributed in the whole volume.  
5.2.4 Dialysis methods 
Crystallization by dialysis methods allow for an easy variation of the different parameters 
that influence the crystallization of biological macromolecules. Different types of dialysis 
cells are used, but follow the same principle. The macromolecule is separated from a large 
volume of solvent by a semi-permeable membrane that gives small molecules free passage, 
but prevents macromolecules from circulating. The kinetics of equilibration will depend on 
the membrane cut-off, the ratio of the concentration, the temperature and the geometry of 
the cell.  
The method of crystallization by interface diffusion was developed (Salemme, 1972) and 
used to crystallize several proteins. In the liquid/liquid diffusion method, equilibration 
occurs by diffusion of the crystallization agent into the biological macromolecule volume. 
To avoid rapid mixing, the less dense solution is poured gently on the most dense (salt in 
general) solution. Sometimes, the crystallizing agent is frozen and the protein layered above 
to avoid rapid mixing. 
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5.3 The role of heterogeneous substrates in the process of protein nucleation and 
crystallization  
In general, additives play an important role in protein crystallization. Heterogeneous 
substrates are usually regarded as additives when they are purposefully added to the 
solution in order to obtain a desired effect (inhibition of nucleation, habit change of crystals). 
However, impurities of foreign substances may also exist in the solution originating from 
other sources (the solvent, crystallization agent, etc.). Heterogeneous crystallization which is 
induced by a properly chosen additive may allow better control of nucleation and growth. 
The first report of a nucleant inducing nucleation of macromolecules was the epitaxial 
growth of protein crystals on minerals (McPherson et al., 1988). Other candidate nucleants 
followed like zeolites, silicates, charged surfaces, porous materials etc. and have been tested 
for multiple proteins (Sugahara et al., 2008, Takehara et al., 2008). Previous results showed 
that horsehair and dried seaweed showed increased hits when added to sparse-matrix 
crystallization trials. The increase in crystallization was 35% when horsehair was added to 
10 test proteins (Thakur et al., 2008). The underlying mechanism is explained with epitaxial 
nucleation in the case of minerals, electrostatic interactions if the nucleants contain charged 
surfaces, nucleation through specific favourable protein-protein interactions or physical 
entrapment in the caves of porous materials. 
Seeding techniques can be advantageous in both screening of crystallization conditions to 
obtain crystals as well in the later optimisation steps. The streak seeding technique may 
provide a fast and effective way to facilitate the optimization of growth conditions without 
the uncertainty that is intrinsic in the process of spontaneous nucleation (Bergfors, 2003). A 
probe for analytical seeding is easily made with an animal whisker mounted with wax to the 
end of a pipette tip. The end of the fibre is then used to touch an existing crystal and 
dislodge seeds from it. Gentle friction against the crystal is normally sufficient. The probe is 
then used to introduce seeds into pre-equilibrated drop by rapidly running the fibre in a 
straight line across the middle of the drop containing protein and precipitant. Sitting drop 
set-ups are preferable since hanging drops tend to evaporate more quickly. 
 
 
Fig. 5. Lysozyme needle crystals growing on sliced human hair as a nucleant, the black bar 
in the left picture represents 200 micrometer. 
6. Combining heterogeneous crystallization and high throughput methods  
A method for the introduction of heterogeneous nucleants in high throughput 
crystallization experiments has recently been developed (Nederlof et al., 2011). The method 
includes preparing of crystallization plates that are locally coated with fragments of human 
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hair, allowing automated, high throughput crystallization trials in a fashion entirely 
compatible with standard vapour diffusion crystallization techniques. The effect of the 
nucleants was assessed on the crystallization of 11 different proteins in more than 4000 
trials. Additional crystallization conditions were found for 10 out of 11 proteins when using 
the standard JCSG+ screen. In total, 34 additional conditions could be identified. The 
increase in crystallization conditions ranged between 33.3% (two additional conditions were 
identified for myoglobin on top of four homogeneous crystallizations) to 1.2% (we identified 
a single additional condition for insulin, which crystallized in 85 out of 96 conditions); the 
median increase in crystallization hits was 14%. The method is straightforward, inexpensive 
and uses materials available in every crystallization lab. 
7. Lab automation  
In recent years, setting up protein crystallisation trials and analysis of the results has become 
largely automated. More and more of the crystallisation methods mentioned in section 5 
have been made amenable to automation, with the sitting drop method still the most 
popular experiment type in this respect. Lab automation includes the use of dispensing 
robots, imaging robots, in situ crystal analysis as well as automated diffraction analysis 
(Stevens et al., 2000, Berry et al., 2006). 
7.1 Automation in dispensing 
Dispensing robots that are used routinely are either specialized for dispensing well recipes 
(e.g. Formulator, MatrixMaker) or drop-setting (NT8, Phoenix, Mosquito), but there are also 
more generic robots that can do both (Hamilton Star, Tecan Evo). In general, the 
experimenter will start crystallisation trials with a set of pre-defined conditions, contained 
in one or more screens. Over 150 of these screens can be bought from commercial vendors in 
a wide range of formats. A number of these are designed on the basis of statistical analysis 
of results obtained at structural genomics initiatives. When initial hits are found with 
screens like these, secondary optimisation experiments need to be performed to produce 
diffracting crystals. In this stage, interaction with a Lab Information Management System 
(LIMS), where experiment design can be coupled to experiment preparation and analysis, 
greatly enhances the potential throughput in a lab and thereby the success rate. There are a 
number of these software packages that can be used to create grid experiments around an 
initial hit condition, as well as randomized sparse-matrix screens based on initial successes. 
7.2 Automated experiment imaging 
Automated experiment analysis is an essential part of the lab setup. Due to the increase in 
throughput obtained by using dispensing robots it is impossible to routinely scan the results 
manually under a microscope. The dynamic nature of these experiments can cause the 
crystallographer to miss events, even crystals. Imaging robots vary from semi-automated 
microscopes with a moving plate stage and camera to fully automated incubators that are 
capable of following all lab experiments from start to finish without human intervention. 
Ideally, images are displayed to the user in the context of the experiment design, so that the 
results are easily interpreted. If this functionality is integrated with the experiment design 
and dispensing the optimisation circle is complete. Such LIMS systems (Bard et al., 2004) can 
be further expanded to follow up on harvested crystals, to assess their diffraction quality 
and finally the structural data derived. (see 7.4) 
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7.3 In situ crystal analysis 
When crystals are found an assessment needs to be made whether the crystals are indeed 
protein crystals or just salt crystals. And the quality of the crystal needs to be established as 
well as their usefulness for collecting diffraction data. It has always been difficult to 
distinguish protein crystals from salt crystals without actually collecting diffraction data. 
Historically, destructive methods have been used like the “crunch” method and protein dyes, 
the idea being that crystals similar to the ones destroyed will have the same properties. These 
methods have not always been conclusive and often the true nature of the crystal was only 
revealed on the X-ray beam. In recent years, three new techniques have been developed in this 
field; in situ diffraction analysis, UV detection and second harmonic microscopy. 
7.3.1 In situ diffraction analysis 
A number of years ago, Oxford Diffraction has come up with a device for X-ray diffraction 
analysis of crystals in the plate where they were grown (Skarzynski 2009, le Maire, et al., 2011). 
The idea is fairly simple, you center a crystal in the X-ray beam using a visual alignment tool 
and you subsequently take a single or a small number of X-ray diffraction images to assess 
whether a crystal is indeed protein, and to get some idea about the diffraction quality 
(mosaicity, resolution). An advantage is that the method is non-invasive (bearing in mind 
potential radiation damage) and fast. The method is not suitable for complete diffraction 
analysis, as the sample can only be rotated by 6°. It is also possible to automatically screen a 
complete crystallisation plate for potential diffraction. When suitably diffracting crystals are 
found they will still needed to be harvested and frozen for complete diffraction analysis. 
7.3.2 UV detection of protein crystals 
An increasing number of imaging devices (see 7.2) make use of a secondary light path in the 
UV range to detect protein crystals. These imagers make use of the fluorescence in UV by 
proteins, mostly caused by tryptophan (Judge et al., 2005). Since the protein concentration in 
the crystal will be much larger than in solution, any protein crystal will light up under UV, 
provided that the protein contains tryptophan. This is a relatively fast and non-invasive 
method, UV illumination can cause some ionisation in the drop, but this effect is much less 
than with X-ray illumination. In order to maximize its use, the experiment media (plates, 
seals) have to be chosen with care, some plastics are not sufficiently translucent in UV, or 
fluoresce themselves, adding noise to the image. One also has to bear in mind that some 
non-protein crystals (ATP, other co-factors added), might also fluoresce in UV. Having 
visible light and UV cameras integrated in a single imaging device greatly enhances its 
usefulness to distinguish protein from salt crystals. 
7.3.3 Second harmonic microscopy  
Fairly recently, a new development in the field of in situ crystal analysis has been reported. 
The technology makes use of a phenomenon called second harmonic generation (SHG), 
more often referred to as “frequency doubling” (Wampler et al., 2008). When an intense 
laser pulse travels through a highly polarizing, non-centrosymmetric material, light emerges 
with exactly half of the wavelength of the incident beam. The explanation is that two 
photons of the incident beam merge, creating a single photon with twice the energy. If the 
incident beam is in the near-infrared, the emerging beam, will be in the visible range. As 
mentioned, the technology requires intense laser light, delivered in femtosecond pulses. 
Most chiral crystal classes, with the exception of octahedral and icosahedral crystals, allow 
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for SHG, thus encompassing over 99% of all protein crystals grown so far. A first 
commercial device using this technology, called SONICC, is available since 2011. When 
combined with a LIMS and a visible light imaging station, SHG can be used to automatically 
score and pre-sort the results for the experimenter. 
7.4 Automated diffraction analysis 
In parallel with automation taking hold of many crystallisation labs, the last part of the 
protein structure analysis pipeline, diffraction analysis in the X-ray beam, is increasingly 
automated as well. Not so long ago, a crystallographer would either measure his/her 
crystals at a home X-ray source or would travel to a synchrotron facility to do so. The 
process involved manually harvesting of the crystals, preparing them for the X-ray beam 
(mounting in a capillary or in a cryoloop, freezing), mounting them manually in the X-ray 
beam, gathering a few trial images to determine optimal settings for exposure, distance etc. 
and finally recording a set of diffraction images to solve the structure. The most time 
consuming steps have now been automated (Cork et al., 2006, Song et al 2007). Most 
notably, crystal mounting robots will now automatically take samples out of a liquid 
nitrogen dewar and place them in the X-ray beam, eliminating the need for the user to enter 
the X-ray hub of the synchrotron after every crystal. At the home lab, the mounted crystals 
are packed in specific dewar compatible with the robot arms at the beamline, and they are 
mailed to the synchrotron. In many synchrotrons, the user now has a choice of having a 
local operator collecting the data, or to drive the computers at the facility remotely from 
their own lab, there is no need to travel to a remote synchrotron anymore. In the near future, 
the automation can be improved by automatic crystal centering routines (Vernede et al., 
2006). With e.g. the use of SHG (see 7.3) crystals can automatically be located inside the cryo 
loops, and this information can be used to automatically center the crystal in the beam. 
8. Conclusions 
The chapter covers some of the main aspects of protein nucleation and crystallization. 
Different diagnostic tools, crystallization techniques and strategies are explained. New 
tendencies in the field such as combining heterogeneous nucleants and high throughput 
methods are also presented.  
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